Translational Development Acquisition (TDAC) Return on Capital Employed (2025 - 2026)

Translational Development Acquisition (TDAC) posted Return on Capital Employed of 0.48% for Q1 2026, up 7.71% on a QoQ basis from 0.52% in Q4 2025.

Translational Development Acquisition (TDAC) Return on Capital Employed (2025 - 2026) Analysis & Trends

Translational Development Acquisition's Return on Capital Employed history runs 2 years deep, the most recent figure standing at 0.48% for Q1 2026.

Quarterly Return on Capital Employed changed N/A year-over-year to 0.48% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48% (changed N/A YoY) and the FY2025 annual result came in at 0.53%, down 31.0% from the prior year.
Return on Capital Employed was 0.48% for Q1 2026 at Translational Development Acquisition, up from 0.52% in the prior quarter.
Across five years, Return on Capital Employed topped out at 0.48% in Q1 2026 and bottomed at 0.52% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	EQV Ventures Acquisition	480.75 Mn	480.75 Mn	-	-0.25%
2	Agriculture & Natural Solutions Acquisition	393.29 Mn	393.29 Mn	-	-1.55%
3	Berto Acquisition	314.56 Mn	314.35 Mn	-	-0.36%
4	GP-Act III Acquisition	313.66 Mn	313.66 Mn	-	-0.18%
5	Centurion Acquisition	311.65 Mn	311.65 Mn	-	-0.22%
6	Republic Digital Acquisition	310.50 Mn	309.63 Mn	-	-0.15%
7	Siddhi Acquisition Corp (Cayman Islands)	288.97 Mn	288.97 Mn	-	-3.13%
8	K&F Growth Acquisition	283.42 Mn	283.42 Mn	-	-0.25%
9	Bold Eagle Acquisition	275.29 Mn	275.29 Mn	-	-0.36%
10	Translational Development Acquisition	186.90 Mn	186.90 Mn	-	-0.48%

Download Data